Merigold Revenue and Competitors
Estimated Revenue & Valuation
- Merigold's estimated annual revenue is currently $2M per year.
- Merigold's estimated revenue per employee is $155,000
Employee Data
- Merigold has 13 Employees.
- Merigold grew their employee count by 8% last year.
Merigold's People
Name | Title | Email/Phone |
---|
Merigold Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Merigold?
We are experienced clinical trialists who specialize in the imaging space. We understand the uniqueness and importance of driving imaging endpoints efficiently. Our focus is imaging study start-up. Think of us as architects for incorporating imaging into a clinical trial design. We offer consulting for imaging clinical trials: Study design Protocol development Implementing image assessment criteria Electronic case report form requirements Budgeting/pricing We offer general and study specific medical writing services: Template creation and/or revision Imaging Charter Imaging Manual Reader Manual Proposals Image acquisition guidelines Analysis platform requirements We offer employee training: Career development and motivation Indication specific training Treatment specific training Response criteria training
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 16 | 0% | $22.5M |
#2 | $3.1M | 19 | 12% | N/A |
#3 | $2M | 20 | N/A | N/A |
#4 | $3.1M | 20 | -5% | N/A |
#5 | $35M | 20 | 11% | N/A |